Navigation Links
Immtech Focusing on Other Infectious Disease Programs Following Discontinuation of Development of Pafuramidine
Date:2/22/2008

nfectious diseases. Immtech has a well defined, expanding library of compounds targeting Hepatitis C, drug- resistant Gram-positive bacteria, fungal infections and other serious diseases. It is expanding its targeted markets by applying its proprietary pharmaceutical platform to treat a range of disorders. Immtech holds exclusive worldwide licenses to certain patents, patent applications and technology for products derived from its proprietary pharmaceutical platform. For additional information, please visit the Company's website at http://www.immtechpharma.com.

This press release contains "forward-looking statements" regarding Immtech Pharmaceuticals, Inc.'s business, including the future prospects for Pneumocystis pneumonia (PCP). Except for historical information, the matters discussed in this press release are "forward-looking statements" and are subject to risks and uncertainties. Actual results could differ materially from these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the following: (i) Immtech's ability to develop commercially viable products; (ii) Immtech's ability to achieve profitability; (iii) Immtech's ability to retain key personnel; (iv) the ability of Immtech's scientists and collaborators to discover new compounds; (v) the availability of additional research grants; (vi) Immtech's ability to obtain regulatory approval of its drug candidates, including PCP; (vii) the success of Immtech's clinical trials; (viii) dependence upon and contractual relationship with partners; (ix) Immtech's ability to manufacture or to contract with a third party to manufacture its drug candidates at a reasonable cost; (x) Immtech's ability to protect its intellectual property; (xi) competition and alternative technologies; (xii) Immtech's ability to obtain reimbursement from third party payers for any product it commercializes; and
'/>"/>

SOURCE Immtech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Immtech Announces Posting of Annual Shareholders Meeting Presentation
2. Immtech Reports Fiscal Second Quarter 2008 Results
3. Immtech to Present at The Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials
5. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
6. Chinese SFDA Grants Immtech Fast Track Status
7. US FDA Grants Orphan Drug Status to Immtechs Pafuramidine for Treatment of African Sleeping Sickness
8. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
9. EnVivo Pharmaceuticals Announces Progress on Major Drug Programs Focusing on Alzheimers, Schizophrenia and Huntingtons Diseases
10. Hopkins Report: Focusing on Family Planning Lessens HIV Impact
11. Cell Genesys Reports Association Between Immune Response and Patient Survival in Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 28, 2015   Eli Lilly and Company ... ) will host a webcast on June 11 to discuss ... baricitinib in rheumatoid arthritis. Data from these two trials, RA-BEACON and ... Programme for the EULAR Congress 2015 in Rome, ... from 10:00 to11:00 a.m. Eastern Daylight Time. The live audio ...
(Date:5/28/2015)... 28, 2015  Merck KGaA, Darmstadt, ... and top-quality high-tech products in healthcare, life science ... agreement with the fertility technologies expert Genea Biomedx, ... and helping couples create families. With this partnership, ... a global market leader in drugs for Assisted ...
(Date:5/28/2015)... CHICAGO , May 28, 2015  The ... left health plans and employer groups scrambling to ... by a major managed care plan, retail pharmacy ... United Healthcare,s $13.3 billion purchase of Catamaran, Rite ... recent announcement to purchase Omni-Care for $10 billion ...
Breaking Medicine Technology:Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data 2Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data 3Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 2Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 3Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 4Citizens Rx Addresses Recent PBM Consolidation and Rising Pharmacy Costs 2Citizens Rx Addresses Recent PBM Consolidation and Rising Pharmacy Costs 3
... , , , , , , ... N.V.,(NASDAQ: QGEN ; Frankfurt , Prime Standard: QIA) today announced ... UV and,fluorescence optical measurement devices. ESE is based in Stockach, Germany ... cash. , ESE has pioneered the development and ...
... N.J., Jan. 11 In conjunction with its fourth quarter 2009 earnings ... Covance Inc. (NYSE: CVD ) is pleased to invite you ... live over the Internet on Thursday, January 28, 2010 at 9:00 a.m. ... Earnings Webcast and Slide Presentation, When: January 28, ...
Cached Medicine Technology:QIAGEN Acquires ESE GmbH 2QIAGEN Acquires ESE GmbH 3QIAGEN Acquires ESE GmbH 4QIAGEN Acquires ESE GmbH 5QIAGEN Acquires ESE GmbH 6QIAGEN Acquires ESE GmbH 7
(Date:5/29/2015)... Gardner, MA (PRWEB) May 29, 2015 ... with investigators from the Clinical Proteomic Tumor Analysis ... of Tryptides™, a new product line of ... The catalog of Tryptides™, or isotope labeled tryptic ... proteins of interest and is now readily accessible ...
(Date:5/28/2015)... Richmond, Kentucky (PRWEB) May 29, 2015 Recently, ... focused on helping amputees regain their quality of life. The ... who may have had one for years, but are still ... there are nearly 2 million people living with limb loss ... vascular disease (54%) – including diabetes and peripheral arterial disease ...
(Date:5/28/2015)... NY (PRWEB) May 28, 2015 The ... Care are proud to present Dr. Alicia Almendral as ... be a big part of the newly opened facility’s ... finest in modern cosmetic treatments. , Dr. Almendral is ... in the latest anti-aging and cosmetic enhancement techniques. Her ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 On Sunday, ... Longest Day®, a team event to honor the strength, ... annually on summer solstice, the duration of this sunrise-to-sunset ... the disease and their caregivers. Participants raise funds and ... of the Alzheimer’s Association. , Teams are encouraged to ...
(Date:5/28/2015)... Dr. Jenyons’ Medical Weight Loss ... to patients looking to undergo its advanced Micro-Needling skin ... will be able to get a single Micro-Needling treatment ... For a three-treatment package, which costs $1,800, the clinic ... , Dr. Juanita Jenyons, M.D., says Dr. Jenyons’ Medical ...
Breaking Medicine News(10 mins):Health News:New England Peptide Announces New Tryptides™ Catalog 2Health News:New England Peptide Announces New Tryptides™ Catalog 3Health News:KORT Richmond Physical Therapy Adds New Program to Help Amputees 2Health News:Bella Diosa Med Spa Welcomes Botox Specialist to Yonkers Community 2Health News:Dr. Jenyons’ Medical Weight Loss & Rejuvenation Center Now Offering Skin Treatment Specials 2Health News:Dr. Jenyons’ Medical Weight Loss & Rejuvenation Center Now Offering Skin Treatment Specials 3
... physician practice reporting, collections and reimbursement; MDs gain financial ... iMedica Corporation , a leading ... announced the availability of its Patient Relationship Manager(TM) ... version of iMedica,s award-winning Electronic Health Record (EHR) and ...
... CE Mark, Application for the Reducer(TM) ... today announced that it intends to undertake a non-brokered ... price of $0.21 per unit for aggregate gross proceeds ... be used for continued development of a suite of ...
... with 100% of Proceeds to Benefit the Al Copeland Foundation ... One year following the passing of legendary New Orleans ... with the Pro Basketball Superstar Chris Paul and the New ... tribute to his memory and raise awareness of Merkel Cell ...
... Know about Making the Case for IT Adoption and ... March 30 Learn why hospitals that invest in ... viewing the next LUMEDX Success in CVIS Webinar Series ... the lead author of "Hospital Adoption of Information Technologies ...
... mark for many claimants; Allsup provides help to claimants who are going ... ... people with disabilities still are experiencing waits as long as two to ... Allsup , which represents tens of thousands of people in the ...
... as Founding Health Care Affiliate, Founding SponsorSAN DIEGO, ... today committed $45 million to create the West Wireless ... dedicated to advancing health and well-being through the use ... as the founding health care affiliate, with Qualcomm as ...
Cached Medicine News:Health News:iMedica Corporation Announces the Release of Patient Relationship Manager 2009 2Health News:iMedica Corporation Announces the Release of Patient Relationship Manager 2009 3Health News:Neovasc to Raise $2 Million in Non-Brokered Private Placement 2Health News:Neovasc to Raise $2 Million in Non-Brokered Private Placement 3Health News:Al Copeland Foundation Signs on as Title Sponsor of 2009 Chris Paul Basketball Camp 2Health News:Al Copeland Foundation Signs on as Title Sponsor of 2009 Chris Paul Basketball Camp 3Health News:The Compelling Evidence-Based Case for Hospital IT Investments: Complimentary Webinar 2Health News:Social Security Disability Applicants' Wait for Benefits Continues 2Health News:Social Security Disability Applicants' Wait for Benefits Continues 3Health News:Social Security Disability Applicants' Wait for Benefits Continues 4Health News:Gary and Mary West Foundation Commits $45 Million to Create Wireless Health Institute 2Health News:Gary and Mary West Foundation Commits $45 Million to Create Wireless Health Institute 3
VACUETTE Trace Element tubes - Non-ridged (pull cap) are designed to test trace elements such as Cu, Zn, Pb, etc....
BD Vacutainer® Specialty Tubes - Trace Element - Plastic...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
... serum tube is specially coated with microscopic ... process. Serum / gel tubes contain a ... tube; during centrifugation, this gel forms a ... blood cells. In the primary tube and ...
Medicine Products: